Longboard Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
LBPH Nasdaq 8731 https://www.longboardpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 - Apr 3rd, 2024 1:00 pm
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Apr 2nd, 2024 8:00 pm
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50% - Mar 27th, 2024 3:17 pm
Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results - Mar 14th, 2024 9:31 am
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates - Mar 12th, 2024 8:01 pm
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February - Feb 1st, 2024 1:30 pm
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher - Jan 17th, 2024 10:51 am
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Jan 8th, 2024 9:05 pm
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Shares Could Be 28% Below Their Intrinsic Value Estimate - Jan 6th, 2024 2:10 pm
Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why - Jan 5th, 2024 1:50 pm
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - Jan 4th, 2024 2:40 am
Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study - Jan 3rd, 2024 2:19 pm
Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally - Jan 2nd, 2024 9:37 pm
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock - Jan 2nd, 2024 9:01 pm
Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs) - Jan 2nd, 2024 1:00 pm
Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs) - Jan 1st, 2024 9:47 pm
Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers - Nov 29th, 2023 1:30 pm
Down -25.05% in 4 Weeks, Here's Why You Should You Buy the Dip in Longboard Pharmaceuticals, Inc. (LBPH) - Nov 24th, 2023 2:35 pm
Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community - Nov 21st, 2023 9:00 pm
Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks - Nov 13th, 2023 7:46 pm